WHO ICTRP trial
Comparison of intranasal midazolam and Dexmedetomidine
IRCT201409141861N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201409141861N5 |
|---|---|
| Public title | Comparison of intranasal midazolam and Dexmedetomidine |
| Scientific title | Comparison the sedative effect of intranasal administration of midazolam and Dexmedetomidine in uncooperative 4 to 6 years of age pediatriientsc dental pat |
| Primary sponsor | Vice chnceller of research and technology |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Sedation. Phobic anxiety disorder of childhood;F-93.1;Phobic anxiety disorder of childhood |
| Interventions | Intervention 1: Control: Midazolam 0.2 mg/kg, 15 minutes before dental treatment. The drug will be calculated by insulin syringe and sprayed without dilution in each nostril in 5 to 10 seconds intervals in semi supine position. Intervention… |
| Registration date | Sep 23, 2014 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: